Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual mon symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
Market Analysis and Insights: Global In-vitro Inflammatory Bowel Disease Diagnostic Market
The global In-vitro Inflammatory Bowel Disease Diagnostic market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for In-vitro Inflammatory Bowel Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for In-vitro Inflammatory Bowel Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for In-vitro Inflammatory Bowel Disease Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of In-vitro Inflammatory Bowel Disease Diagnostic include DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Quidel Corporation, American Laboratory Products Company (ALPCO), Certest Biotec SL. and Biosystems S.A., etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for In-vitro Inflammatory Bowel Disease Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of In-vitro Inflammatory Bowel Disease Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In-vitro Inflammatory Bowel Disease Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In-vitro Inflammatory Bowel Disease Diagnostic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global In-vitro Inflammatory Bowel Disease Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for In-vitro Inflammatory Bowel Disease Diagnostic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Quidel Corporation, American Laboratory Products Company (ALPCO), Certest Biotec SL. and Biosystems S.A., etc.
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of In-vitro Inflammatory Bowel Disease Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Inflammatory Bowel Disease Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-vitro Inflammatory Bowel Disease Diagnostic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2018-2029)
2.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Region
2.2.1 In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Dynamics
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Industry Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In-vitro Inflammatory Bowel Disease Diagnostic by Players
3.1.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Players (2018-2023)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2022
3.5 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic Head office and Area Served
3.6 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Product and Application
3.7 Global Key Players of In-vitro Inflammatory Bowel Disease Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2024-2029)
5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
6.2.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2018-2023)
6.2.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2024-2029)
6.2.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2018-2029)
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
6.3.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2018-2023)
6.3.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2024-2029)
6.3.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2018-2029)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
6.4.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
6.4.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
7.2.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2018-2023)
7.2.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2024-2029)
7.2.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2018-2029)
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
7.3.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2018-2023)
7.3.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2024-2029)
7.3.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2018-2029)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
7.4.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
7.4.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
8.2 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
8.2.1 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2018-2023)
8.2.2 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2024-2029)
8.2.3 China In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2018-2029)
8.3 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
8.3.1 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2018-2023)
8.3.2 China In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2024-2029)
8.3.3 China In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
9.2 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
9.2.1 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2018-2023)
9.2.2 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2024-2029)
9.2.3 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2018-2029)
9.3 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
9.3.1 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2018-2023)
9.3.2 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2024-2029)
9.3.3 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2018-2029)
9.4 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region
9.4.1 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2018-2023)
9.4.3 Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type
10.2.1 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application
10.3.1 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country
10.4.1 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Details
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.1.5 DiaSorin S.p.A Recent Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Ltd Recent Developments
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Details
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.3.5 Siemens Healthineers AG Recent Developments
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.4.5 Abbott Recent Developments
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Details
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.5.5 Quidel Corporation Recent Developments
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Details
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.6.5 American Laboratory Products Company (ALPCO) Recent Developments
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Details
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.7.5 Certest Biotec SL. Recent Developments
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Details
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2018-2023)
11.8.5 Biosystems S.A. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
*If Applicable.